MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 14, 2006; DOI: 10.1124/mol.106.027169


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.106.027169v1
71/2/446    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyoudou, K.
Right arrow Articles by Hashida, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyoudou, K.
Right arrow Articles by Hashida, M.


Received for publication May 25, 2006.
Revised November 12, 2006.
Accepted for publication November 14, 2006.

Analysis of in vivo NF-kappaB Activation during Liver Inflammation in Mice: Prevention by Catalase Delivery

Kenji Hyoudou 1, Makiya Nishikawa 2*, Yuki Kobayashi 1, Yukari Kuramoto 1, Fumiyoshi Yamashita 1, Mitsuru Hashida 1

1 Graduate School of Pharmaceutical Sciences, Kyoto University 2 Kyoto University Graduate School of Pharmaceutical Sciences

* Address correspondence to: E-mail: makiya{at}pharm.kyoto-u.ac.jp

Abstract

Nuclear factor {kappa}B (NF-{kappa}B) is a transcription factor that plays crucial roles in inflammation, immunity, cell proliferation and apoptosis. Until now, there have been few studies of NF-{kappa}B activation in whole animals, because of experimental difficulties. Here, we show that mice receiving a simple injection of plasmid vectors can be used to examine NF-{kappa}B activation in the liver. Two plasmid vectors, pNF-{kappa}B-Luc (firefly luciferase gene) and pRL-SV40 (renilla luciferase gene), were injected into the tail vein of mice by the hydrodynamics-based procedure, an established method of gene transfer to mouse liver. Then, the ratio of the firefly and renilla luciferase activities (F/R) was used as an indicator of the NF-{kappa}B activity in the liver. Injection of thioacetamide or lipopolysaccharide plus D-galactosamine increased the F/R ratio in the liver and this was significantly (P<0.001) inhibited by an intravenous injection of catalase derivatives targeting liver nonparenchymal cells. Imaging the firefly luciferase expression in live mice clearly demonstrated that the catalase derivatives efficiently prevented the NF-{kappa}B-mediated expression of the firefly luciferase gene. Plasma transaminases and the survival rate of mice supported the findings obtained by the luminescence-based analyses. Thus, this method, which requires no genetic recombination techniques, is highly sensitive to the activation of NF-{kappa}B, and allows us to continuously examine the activation in live animals. In conclusion, this novel, simple and sensitive method can be used not only for analyzing the NF-{kappa}B activation in the organ under different inflammatory conditions, but also for screening drug candidates for the prevention of liver inflammation.


Key words: NFkappaB, Regulation of gene expression, Receptor-mediated, Regulation - transcriptional, Oxidative stress





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics